Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

ADPT

Adaptive Biotechnologies Corp

CIK 0001478320 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$21.80
↑ 1.64 (8.13%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals, Options

Key stats

Market Cap
$3.49B
P/E Ratio
-70.23
EPS
-0.39
Dividend Yield
Not covered
52W Position
92%
Beta
1.88

Valuation multiples

Fwd P/E
Not covered
PEG
0.00
P/B
15.56
P/S
11.81
EV/Revenue
11.99
ROE
-22.2%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 92%
$9.96$22.80

Latest Financials

2025-12-31 FY
Revenue
$276.98M
Net Income
-$59.50M
Total Assets
$512.74M
Free Cash Flow
-$48.95M

Recent news